Medicine
Provigil 200 mg tablet
Provigil 200 mg tablet is a prescription medicine containing Modafinil for oral use, marketed by Apotex, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 • C-25 • C (68 • F-77 • F).
Key facts
- Active ingredient (INN)
- Modafinil
- Brand
- Provigil
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Apotex
- Manufacturers
- ApotexCephalonGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20 • C-25 • C (68 • F-77 • F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N06BA07 Modafinil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 December 1998
- Identifiers
- RxCUI 205324, 213471, 226426 +1DailyMed set ID 3b8d1c32-dac9-50e6-e063-6394a90aa5a5, 0391f182-1958-9fef-a944-53b229ce99e7, e16c26ad-7bc2-d155-3a5d-da83ad6492c8NDC 60429-010, 60505-4852, 63459-201Application NDA020717
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 60505-4852-3 | Apotex | 31 August 2025 |
| 30 tablet in 1 bottle | 63459-201-30 | Cephalon | 3 January 2011 |
| 30 tablet in 1 bottle | 60429-010-30 | Golden State Medical Supply | 8 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 December 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Modafinil 200 mg tablet.
Other strengths and forms of Modafinil
Clinical summary
Modafinil is a sympathomimetic-like agent indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). It is available as tablets for oral use. MedsAcross supplies Modafinil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ModafinilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Provigil prescribing information (Apotex) · U.S. National Library of Medicine, DailyMed
Need Provigil 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.